A Study of HDM1005 in Participants With T2DM Not Controlled With Metformin Alone or in Combination With a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor
Clinical trial NCT07417306 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07417306
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-27
- Primary completion
- 2027-08-30
- Enrollment
- 912
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.